Rise Advisors’s Aemetis AMTX Stock Holding History

Rise Advisors’s Portfolio AMTX Stock Details AMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-251	Closed	-$437	–	1544
2025 Q1	$437	Buy	+251	New	+$537	﹤0.01%	1396

Other funds holding AMTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Rise Advisors's AMTX Position: Q2 2025 in Review

Rise Advisors sold out of Aemetis (AMTX) in Q2 2025, closing a stake of 251 shares — an estimated $437 sold.

Rise Advisors first reported a position in AMTX in Q1 2025 and held it in 1 quarter. The position peaked at $437 in Q1 2025. 71 funds tracked by Wall St. Rank hold AMTX as of Q2 2025.

Rise Advisors reported no remaining Aemetis position as of Q2 2025 after selling out during the quarter.
Rise Advisors sold 251 Aemetis shares in Q2 2025, an estimated $437.
Rise Advisors first reported a position in Aemetis in Q1 2025 and held it in 1 quarter.
Rise Advisors's Aemetis position peaked at $437 in Q1 2025.
71 funds tracked by Wall St. Rank held Aemetis as of Q2 2025.

Based on Rise Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.